Skip to main content

Table 2 Changes in clinical serum chemistry and complete blood count variables

From: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion

Variable Group Day 0 Day 28 Significance
Triglycerides
(mg·dl-1)
TD
PLA
94 ± 8
94 ± 7
105 ± 9
98 ± 7
Group:
Time:
G × T:
0.77
0.10
0.44
Total Chol
(mg·dl-1)
TD
PLA
162 ± 5
165 ± 6
164 ± 5
168 ± 5
Group:
Time:
G × T:
0.61
0.32
0.99
HDL Chol
(mg·dl-1)
TD
PLA
58 ± 3
54 ± 2
57 ± 3
54 ± 2
Group:
Time:
G × T:
0.33
0.92
0.44
LDL Chol
(mg·dl-1)
TD
PLA
85 ± 4
94 ± 6
86 ± 5
94 ± 5
Group:
Time:
G × T:
0.26
0.73
0.91
Glucose
(mg·dl-1)
TD
PLA
94 ± 1
91 ± 1
96 ± 1
92 ± 1
Group:
Time:
G × T:
0.07
0.06
0.52
Sodium
(mM)
TD
PLA
141 ± 1
141 ± 1
142 ± 2
142 ± 2
Group:
Time:
G × T:
0.93
0.03
0.96
Potassium
(mM)
TD
PLA
4.4 ± 0.1
4.5 ± 0.1
4.5 ± 0.1
4.6 ± 0.1
Group:
Time:
G × T:
0.20
0.41
0.96
BUN
(mg·dl-1)
TD
PLA
14 ± 1
14 ± 1
14 ± 1
13 ± 1
Group:
Time:
G × T:
0.63
0.35
0.36
Creatinine
(mg·dl-1)
TD
PLA
1.0 ± 0.0
1.0 ± 0.0
1.0 ± 0.0
1.0 ± 0.0
Group:
Time:
G × T:
0.46
0.007
0.42
ALT
(U·L-1)
TD
PLA
20 ± 2
19 ± 1
18 ± 1
18 ± 1
Group:
Time:
G × T:
0.69
0.12
0.51
AST
(U·L-1)
TD
PLA
20 ± 1
20 ± 1
20 ± 1
21 ± 2
Group:
Time:
G × T:
0.94
0.53
0.74
RBC Count
(106·μl-1)
TD
PLA
5.00 ± 0.12
4.91 ± 0.14
4.63 ± 0.08
4.62 ± 0.10
Group:
Time:
G × T:
0.75
< 0.001
0.68
Hemoglobin
(g·dl-1)
TD
PLA
14.5 ± 0.2
14.8 ± 0.3
14.2 ± 0.2
14.4 ± 0.3
Group:
Time:
G × T:
0.42
0.003
0.50
Hematocrit
(%)
TD
PLA
43.6 ± 1.6
42.7 ± 0.8
40.8 ± 0.7
41.0 ± 0.9
Group:
Time:
G × T:
0.78
0.02
0.56
WBC Count
(103·μl-1)
TD
PLA
5.9 ± 0.2
5.9 ± 0.2
5.8 ± 0.2
6.1 ± 0.2
Group:
Time:
G × T:
0.63
0.95
0.36
  1. TD, thermogenic drink group (n = 30)
  2. PLA, placebo group (n = 30)
  3. Values are expressed as means ± SE
  4. Significant main effect for time, p < 0.05